Edwards Lifesciences | EW - Current Assets

Stock Price
82.08
Daily Change
2.30 2.88%
Monthly
-2.60%
Yearly
12.81%
Q1 Forecast
77.31

Edwards Lifesciences reported $6.36B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Artivion USD 337.5M 18.68M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
ICU Medical USD 1.19B 16.74M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 24B 773M Sep/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.99B 262.12M Sep/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025